Septic cardiomyopathy
1 paper
- Animals1
Latest
1 in 12 monthsInternational Immunopharmacology
Anemoside B4 ameliorates septic cardiomyopathy by activating SRC-mediated PI3K/AKT/mTOR pathway to alleviate mitochondrial dysfunction and cardiomyocyte senescence
Experiments in miceInterventions